| Wholeness Healing Center Pc | |
|
2608 Old Fair Rd Grand Island NE 68803-5271 | |
| (308) 382-5297 | |
| (308) 382-5315 |
| Full Name | Wholeness Healing Center Pc |
|---|---|
| Speciality | Counselor |
| Location | 2608 Old Fair Rd, Grand Island, Nebraska |
| Authorized Official Name and Position | Jane L Watson (OWNER, DIRECTOR) |
| Authorized Official Contact | 3083825297 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Wholeness Healing Center Pc 2608 Old Fair Rd Grand Island NE 68803-5271 Ph: (308) 382-5297 | Wholeness Healing Center Pc 2608 Old Fair Rd Grand Island NE 68803-5271 Ph: (308) 382-5297 |
| NPI Number | 1124130364 |
|---|---|
| Provider Enumeration Date | 08/31/2006 |
| Last Update Date | 05/16/2023 |
| Certification Date | 05/16/2023 |
| Medicare PECOS PAC ID | 3173571320 |
|---|---|
| Medicare Enrollment ID | O20050105000266 |
News Archive
The World Health Organization (WHO) and the Institute of Health Metrics and Evaluation (IHME) today signed a Memorandum of Understanding defining areas where they will work together to improve the quality and use of global health estimates to measure the world's health challenges...
A follow-up analysis of patients enrolled in a Phase I/II multi-center trial for diffuse large B-cell lymphoma reported 51 percent of patients receiving an anti-CD19 chimeric antigen receptor (CAR T) called axi-cel were still alive two years post-treatment.
Certain white blood cells play an important role in bringing a harmful virus under control after kidney transplantations. The results of a research group at the Department of Biomedicine at the University of Basel and University Hospital Basel could contribute to improving control of immunosuppression, avoiding transplant rejection and developing relevant vaccines.
Arginine therapy may be a safe and inexpensive treatment for acute pain episodes in patients with sickle cell disease, according to results of a recent clinical study. The study was the first randomized placebo-controlled study to demonstrate benefits of arginine therapy in children with sickle cell disease hospitalized for severe pain.
› Verified 6 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124130364 | NPI | - | NPPES |
| 10025173200 | Medicaid | NE | |
| 10025173100 | Medicaid | NE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
| Provider Name | Jane L Watson |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1770688657 PECOS PAC ID: 6305829268 Enrollment ID: I20040611000033 |
News Archive
The World Health Organization (WHO) and the Institute of Health Metrics and Evaluation (IHME) today signed a Memorandum of Understanding defining areas where they will work together to improve the quality and use of global health estimates to measure the world's health challenges...
A follow-up analysis of patients enrolled in a Phase I/II multi-center trial for diffuse large B-cell lymphoma reported 51 percent of patients receiving an anti-CD19 chimeric antigen receptor (CAR T) called axi-cel were still alive two years post-treatment.
Certain white blood cells play an important role in bringing a harmful virus under control after kidney transplantations. The results of a research group at the Department of Biomedicine at the University of Basel and University Hospital Basel could contribute to improving control of immunosuppression, avoiding transplant rejection and developing relevant vaccines.
Arginine therapy may be a safe and inexpensive treatment for acute pain episodes in patients with sickle cell disease, according to results of a recent clinical study. The study was the first randomized placebo-controlled study to demonstrate benefits of arginine therapy in children with sickle cell disease hospitalized for severe pain.
› Verified 6 days ago
| Provider Name | Jody A Johnson |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1760680797 PECOS PAC ID: 6204937584 Enrollment ID: I20070731000418 |
News Archive
The World Health Organization (WHO) and the Institute of Health Metrics and Evaluation (IHME) today signed a Memorandum of Understanding defining areas where they will work together to improve the quality and use of global health estimates to measure the world's health challenges...
A follow-up analysis of patients enrolled in a Phase I/II multi-center trial for diffuse large B-cell lymphoma reported 51 percent of patients receiving an anti-CD19 chimeric antigen receptor (CAR T) called axi-cel were still alive two years post-treatment.
Certain white blood cells play an important role in bringing a harmful virus under control after kidney transplantations. The results of a research group at the Department of Biomedicine at the University of Basel and University Hospital Basel could contribute to improving control of immunosuppression, avoiding transplant rejection and developing relevant vaccines.
Arginine therapy may be a safe and inexpensive treatment for acute pain episodes in patients with sickle cell disease, according to results of a recent clinical study. The study was the first randomized placebo-controlled study to demonstrate benefits of arginine therapy in children with sickle cell disease hospitalized for severe pain.
› Verified 6 days ago
| Provider Name | Josephine K Studnicka |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1851684450 PECOS PAC ID: 0143498410 Enrollment ID: I20110713000259 |
News Archive
The World Health Organization (WHO) and the Institute of Health Metrics and Evaluation (IHME) today signed a Memorandum of Understanding defining areas where they will work together to improve the quality and use of global health estimates to measure the world's health challenges...
A follow-up analysis of patients enrolled in a Phase I/II multi-center trial for diffuse large B-cell lymphoma reported 51 percent of patients receiving an anti-CD19 chimeric antigen receptor (CAR T) called axi-cel were still alive two years post-treatment.
Certain white blood cells play an important role in bringing a harmful virus under control after kidney transplantations. The results of a research group at the Department of Biomedicine at the University of Basel and University Hospital Basel could contribute to improving control of immunosuppression, avoiding transplant rejection and developing relevant vaccines.
Arginine therapy may be a safe and inexpensive treatment for acute pain episodes in patients with sickle cell disease, according to results of a recent clinical study. The study was the first randomized placebo-controlled study to demonstrate benefits of arginine therapy in children with sickle cell disease hospitalized for severe pain.
› Verified 6 days ago
| Provider Name | Nadine J Stuehm |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1912307083 PECOS PAC ID: 4385953074 Enrollment ID: I20151020001743 |
News Archive
The World Health Organization (WHO) and the Institute of Health Metrics and Evaluation (IHME) today signed a Memorandum of Understanding defining areas where they will work together to improve the quality and use of global health estimates to measure the world's health challenges...
A follow-up analysis of patients enrolled in a Phase I/II multi-center trial for diffuse large B-cell lymphoma reported 51 percent of patients receiving an anti-CD19 chimeric antigen receptor (CAR T) called axi-cel were still alive two years post-treatment.
Certain white blood cells play an important role in bringing a harmful virus under control after kidney transplantations. The results of a research group at the Department of Biomedicine at the University of Basel and University Hospital Basel could contribute to improving control of immunosuppression, avoiding transplant rejection and developing relevant vaccines.
Arginine therapy may be a safe and inexpensive treatment for acute pain episodes in patients with sickle cell disease, according to results of a recent clinical study. The study was the first randomized placebo-controlled study to demonstrate benefits of arginine therapy in children with sickle cell disease hospitalized for severe pain.
› Verified 6 days ago
| Provider Name | Erica J Hardessen Edwards |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1477955813 PECOS PAC ID: 2365732724 Enrollment ID: I20160526001609 |
News Archive
The World Health Organization (WHO) and the Institute of Health Metrics and Evaluation (IHME) today signed a Memorandum of Understanding defining areas where they will work together to improve the quality and use of global health estimates to measure the world's health challenges...
A follow-up analysis of patients enrolled in a Phase I/II multi-center trial for diffuse large B-cell lymphoma reported 51 percent of patients receiving an anti-CD19 chimeric antigen receptor (CAR T) called axi-cel were still alive two years post-treatment.
Certain white blood cells play an important role in bringing a harmful virus under control after kidney transplantations. The results of a research group at the Department of Biomedicine at the University of Basel and University Hospital Basel could contribute to improving control of immunosuppression, avoiding transplant rejection and developing relevant vaccines.
Arginine therapy may be a safe and inexpensive treatment for acute pain episodes in patients with sickle cell disease, according to results of a recent clinical study. The study was the first randomized placebo-controlled study to demonstrate benefits of arginine therapy in children with sickle cell disease hospitalized for severe pain.
› Verified 6 days ago
| Provider Name | Michelle Diane Stoller |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1043680622 PECOS PAC ID: 1153682794 Enrollment ID: I20180223000124 |
News Archive
The World Health Organization (WHO) and the Institute of Health Metrics and Evaluation (IHME) today signed a Memorandum of Understanding defining areas where they will work together to improve the quality and use of global health estimates to measure the world's health challenges...
A follow-up analysis of patients enrolled in a Phase I/II multi-center trial for diffuse large B-cell lymphoma reported 51 percent of patients receiving an anti-CD19 chimeric antigen receptor (CAR T) called axi-cel were still alive two years post-treatment.
Certain white blood cells play an important role in bringing a harmful virus under control after kidney transplantations. The results of a research group at the Department of Biomedicine at the University of Basel and University Hospital Basel could contribute to improving control of immunosuppression, avoiding transplant rejection and developing relevant vaccines.
Arginine therapy may be a safe and inexpensive treatment for acute pain episodes in patients with sickle cell disease, according to results of a recent clinical study. The study was the first randomized placebo-controlled study to demonstrate benefits of arginine therapy in children with sickle cell disease hospitalized for severe pain.
› Verified 6 days ago
| Provider Name | Riley Jean Smith |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1730725201 PECOS PAC ID: 5799118741 Enrollment ID: I20191204002134 |
News Archive
The World Health Organization (WHO) and the Institute of Health Metrics and Evaluation (IHME) today signed a Memorandum of Understanding defining areas where they will work together to improve the quality and use of global health estimates to measure the world's health challenges...
A follow-up analysis of patients enrolled in a Phase I/II multi-center trial for diffuse large B-cell lymphoma reported 51 percent of patients receiving an anti-CD19 chimeric antigen receptor (CAR T) called axi-cel were still alive two years post-treatment.
Certain white blood cells play an important role in bringing a harmful virus under control after kidney transplantations. The results of a research group at the Department of Biomedicine at the University of Basel and University Hospital Basel could contribute to improving control of immunosuppression, avoiding transplant rejection and developing relevant vaccines.
Arginine therapy may be a safe and inexpensive treatment for acute pain episodes in patients with sickle cell disease, according to results of a recent clinical study. The study was the first randomized placebo-controlled study to demonstrate benefits of arginine therapy in children with sickle cell disease hospitalized for severe pain.
› Verified 6 days ago
| Provider Name | Elizabeth Ann Todd |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1740764372 PECOS PAC ID: 0244661221 Enrollment ID: I20200506002196 |
News Archive
The World Health Organization (WHO) and the Institute of Health Metrics and Evaluation (IHME) today signed a Memorandum of Understanding defining areas where they will work together to improve the quality and use of global health estimates to measure the world's health challenges...
A follow-up analysis of patients enrolled in a Phase I/II multi-center trial for diffuse large B-cell lymphoma reported 51 percent of patients receiving an anti-CD19 chimeric antigen receptor (CAR T) called axi-cel were still alive two years post-treatment.
Certain white blood cells play an important role in bringing a harmful virus under control after kidney transplantations. The results of a research group at the Department of Biomedicine at the University of Basel and University Hospital Basel could contribute to improving control of immunosuppression, avoiding transplant rejection and developing relevant vaccines.
Arginine therapy may be a safe and inexpensive treatment for acute pain episodes in patients with sickle cell disease, according to results of a recent clinical study. The study was the first randomized placebo-controlled study to demonstrate benefits of arginine therapy in children with sickle cell disease hospitalized for severe pain.
› Verified 6 days ago
| Provider Name | Ruth M Jones |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1760019467 PECOS PAC ID: 2769801026 Enrollment ID: I20201006001548 |
News Archive
The World Health Organization (WHO) and the Institute of Health Metrics and Evaluation (IHME) today signed a Memorandum of Understanding defining areas where they will work together to improve the quality and use of global health estimates to measure the world's health challenges...
A follow-up analysis of patients enrolled in a Phase I/II multi-center trial for diffuse large B-cell lymphoma reported 51 percent of patients receiving an anti-CD19 chimeric antigen receptor (CAR T) called axi-cel were still alive two years post-treatment.
Certain white blood cells play an important role in bringing a harmful virus under control after kidney transplantations. The results of a research group at the Department of Biomedicine at the University of Basel and University Hospital Basel could contribute to improving control of immunosuppression, avoiding transplant rejection and developing relevant vaccines.
Arginine therapy may be a safe and inexpensive treatment for acute pain episodes in patients with sickle cell disease, according to results of a recent clinical study. The study was the first randomized placebo-controlled study to demonstrate benefits of arginine therapy in children with sickle cell disease hospitalized for severe pain.
› Verified 6 days ago
| Provider Name | Jessica C Kingsley |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1528372166 PECOS PAC ID: 1254570302 Enrollment ID: I20201022000246 |
News Archive
The World Health Organization (WHO) and the Institute of Health Metrics and Evaluation (IHME) today signed a Memorandum of Understanding defining areas where they will work together to improve the quality and use of global health estimates to measure the world's health challenges...
A follow-up analysis of patients enrolled in a Phase I/II multi-center trial for diffuse large B-cell lymphoma reported 51 percent of patients receiving an anti-CD19 chimeric antigen receptor (CAR T) called axi-cel were still alive two years post-treatment.
Certain white blood cells play an important role in bringing a harmful virus under control after kidney transplantations. The results of a research group at the Department of Biomedicine at the University of Basel and University Hospital Basel could contribute to improving control of immunosuppression, avoiding transplant rejection and developing relevant vaccines.
Arginine therapy may be a safe and inexpensive treatment for acute pain episodes in patients with sickle cell disease, according to results of a recent clinical study. The study was the first randomized placebo-controlled study to demonstrate benefits of arginine therapy in children with sickle cell disease hospitalized for severe pain.
› Verified 6 days ago
| Provider Name | Jody L Detwieler |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1962622746 PECOS PAC ID: 6800204942 Enrollment ID: I20210409001058 |
News Archive
The World Health Organization (WHO) and the Institute of Health Metrics and Evaluation (IHME) today signed a Memorandum of Understanding defining areas where they will work together to improve the quality and use of global health estimates to measure the world's health challenges...
A follow-up analysis of patients enrolled in a Phase I/II multi-center trial for diffuse large B-cell lymphoma reported 51 percent of patients receiving an anti-CD19 chimeric antigen receptor (CAR T) called axi-cel were still alive two years post-treatment.
Certain white blood cells play an important role in bringing a harmful virus under control after kidney transplantations. The results of a research group at the Department of Biomedicine at the University of Basel and University Hospital Basel could contribute to improving control of immunosuppression, avoiding transplant rejection and developing relevant vaccines.
Arginine therapy may be a safe and inexpensive treatment for acute pain episodes in patients with sickle cell disease, according to results of a recent clinical study. The study was the first randomized placebo-controlled study to demonstrate benefits of arginine therapy in children with sickle cell disease hospitalized for severe pain.
› Verified 6 days ago
| Provider Name | Valerie Joy Harris |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1386271419 PECOS PAC ID: 9032549076 Enrollment ID: I20210908002161 |
News Archive
The World Health Organization (WHO) and the Institute of Health Metrics and Evaluation (IHME) today signed a Memorandum of Understanding defining areas where they will work together to improve the quality and use of global health estimates to measure the world's health challenges...
A follow-up analysis of patients enrolled in a Phase I/II multi-center trial for diffuse large B-cell lymphoma reported 51 percent of patients receiving an anti-CD19 chimeric antigen receptor (CAR T) called axi-cel were still alive two years post-treatment.
Certain white blood cells play an important role in bringing a harmful virus under control after kidney transplantations. The results of a research group at the Department of Biomedicine at the University of Basel and University Hospital Basel could contribute to improving control of immunosuppression, avoiding transplant rejection and developing relevant vaccines.
Arginine therapy may be a safe and inexpensive treatment for acute pain episodes in patients with sickle cell disease, according to results of a recent clinical study. The study was the first randomized placebo-controlled study to demonstrate benefits of arginine therapy in children with sickle cell disease hospitalized for severe pain.
› Verified 6 days ago
| Provider Name | Christina Danielle Larsen |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1568036390 PECOS PAC ID: 4486003415 Enrollment ID: I20231215000577 |
News Archive
The World Health Organization (WHO) and the Institute of Health Metrics and Evaluation (IHME) today signed a Memorandum of Understanding defining areas where they will work together to improve the quality and use of global health estimates to measure the world's health challenges...
A follow-up analysis of patients enrolled in a Phase I/II multi-center trial for diffuse large B-cell lymphoma reported 51 percent of patients receiving an anti-CD19 chimeric antigen receptor (CAR T) called axi-cel were still alive two years post-treatment.
Certain white blood cells play an important role in bringing a harmful virus under control after kidney transplantations. The results of a research group at the Department of Biomedicine at the University of Basel and University Hospital Basel could contribute to improving control of immunosuppression, avoiding transplant rejection and developing relevant vaccines.
Arginine therapy may be a safe and inexpensive treatment for acute pain episodes in patients with sickle cell disease, according to results of a recent clinical study. The study was the first randomized placebo-controlled study to demonstrate benefits of arginine therapy in children with sickle cell disease hospitalized for severe pain.
› Verified 6 days ago
| Provider Name | Dorothy Ruth Molczyk |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1942362546 PECOS PAC ID: 1951750918 Enrollment ID: I20231215001884 |
News Archive
The World Health Organization (WHO) and the Institute of Health Metrics and Evaluation (IHME) today signed a Memorandum of Understanding defining areas where they will work together to improve the quality and use of global health estimates to measure the world's health challenges...
A follow-up analysis of patients enrolled in a Phase I/II multi-center trial for diffuse large B-cell lymphoma reported 51 percent of patients receiving an anti-CD19 chimeric antigen receptor (CAR T) called axi-cel were still alive two years post-treatment.
Certain white blood cells play an important role in bringing a harmful virus under control after kidney transplantations. The results of a research group at the Department of Biomedicine at the University of Basel and University Hospital Basel could contribute to improving control of immunosuppression, avoiding transplant rejection and developing relevant vaccines.
Arginine therapy may be a safe and inexpensive treatment for acute pain episodes in patients with sickle cell disease, according to results of a recent clinical study. The study was the first randomized placebo-controlled study to demonstrate benefits of arginine therapy in children with sickle cell disease hospitalized for severe pain.
› Verified 6 days ago
| Provider Name | Melanie Grace Gabbert |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1235277039 PECOS PAC ID: 9234588120 Enrollment ID: I20231218003554 |
News Archive
The World Health Organization (WHO) and the Institute of Health Metrics and Evaluation (IHME) today signed a Memorandum of Understanding defining areas where they will work together to improve the quality and use of global health estimates to measure the world's health challenges...
A follow-up analysis of patients enrolled in a Phase I/II multi-center trial for diffuse large B-cell lymphoma reported 51 percent of patients receiving an anti-CD19 chimeric antigen receptor (CAR T) called axi-cel were still alive two years post-treatment.
Certain white blood cells play an important role in bringing a harmful virus under control after kidney transplantations. The results of a research group at the Department of Biomedicine at the University of Basel and University Hospital Basel could contribute to improving control of immunosuppression, avoiding transplant rejection and developing relevant vaccines.
Arginine therapy may be a safe and inexpensive treatment for acute pain episodes in patients with sickle cell disease, according to results of a recent clinical study. The study was the first randomized placebo-controlled study to demonstrate benefits of arginine therapy in children with sickle cell disease hospitalized for severe pain.
› Verified 6 days ago
| Provider Name | Carolyn Diane Haney |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1871756965 PECOS PAC ID: 3678918398 Enrollment ID: I20240304001590 |
News Archive
The World Health Organization (WHO) and the Institute of Health Metrics and Evaluation (IHME) today signed a Memorandum of Understanding defining areas where they will work together to improve the quality and use of global health estimates to measure the world's health challenges...
A follow-up analysis of patients enrolled in a Phase I/II multi-center trial for diffuse large B-cell lymphoma reported 51 percent of patients receiving an anti-CD19 chimeric antigen receptor (CAR T) called axi-cel were still alive two years post-treatment.
Certain white blood cells play an important role in bringing a harmful virus under control after kidney transplantations. The results of a research group at the Department of Biomedicine at the University of Basel and University Hospital Basel could contribute to improving control of immunosuppression, avoiding transplant rejection and developing relevant vaccines.
Arginine therapy may be a safe and inexpensive treatment for acute pain episodes in patients with sickle cell disease, according to results of a recent clinical study. The study was the first randomized placebo-controlled study to demonstrate benefits of arginine therapy in children with sickle cell disease hospitalized for severe pain.
› Verified 6 days ago
News Archive
The World Health Organization (WHO) and the Institute of Health Metrics and Evaluation (IHME) today signed a Memorandum of Understanding defining areas where they will work together to improve the quality and use of global health estimates to measure the world's health challenges...
A follow-up analysis of patients enrolled in a Phase I/II multi-center trial for diffuse large B-cell lymphoma reported 51 percent of patients receiving an anti-CD19 chimeric antigen receptor (CAR T) called axi-cel were still alive two years post-treatment.
Certain white blood cells play an important role in bringing a harmful virus under control after kidney transplantations. The results of a research group at the Department of Biomedicine at the University of Basel and University Hospital Basel could contribute to improving control of immunosuppression, avoiding transplant rejection and developing relevant vaccines.
Arginine therapy may be a safe and inexpensive treatment for acute pain episodes in patients with sickle cell disease, according to results of a recent clinical study. The study was the first randomized placebo-controlled study to demonstrate benefits of arginine therapy in children with sickle cell disease hospitalized for severe pain.
› Verified 6 days ago
Rebekah Shunkwiler Counseling Services, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1811 W 2nd St, Suite 360, Grand Island, NE 68803 Phone: 308-385-8404 | |
Visinet, Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1020 W 2nd St, Grand Island, NE 68801 Phone: 308-398-4662 Fax: 308-398-4665 | |
M H Solutions Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1811 W 2nd St, Suite 245, Grand Island, NE 68803 Phone: 308-384-4739 Fax: 308-384-9195 | |
Crane River Clinic Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 3280 Woodridge Blvd, Suite 260, Grand Island, NE 68801 Phone: 308-389-5359 Fax: 308-381-4838 | |
Professional Care Counseling Service Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 205 S Cedar St, Grand Island, NE 68801 Phone: 308-370-1667 Fax: 402-298-2523 | |
Family Network Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 1811 W 2nd St, Suite 330, Grand Island, NE 68803 Phone: 308-382-8085 Fax: 308-382-2582 |